10
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Substance Abuse and HIV/AIDS in Poland: Opportunities for Educational Exchange

&
Pages 101-109 | Published online: 01 Dec 2009
 

Abstract

Since democratization, Poland has focused increased attention on the care of injection drug users. The growing epidemic of HIV in this population has heightened concerns about effective substance abuse treatment and medical care for those who are infected. A collaborative effort between Yale University and the Medical University of Gdańsk, Poland, is responding to these issues. This collaboration provides the opportunity for Polish and American faculty to share clinical treatment approaches and develop research activities investigating mutual concerns regarding care of injection-drug users with HIV infection. The addiction problem in Poland is characterized by the injection of a home-grown opioid referred to as “kompot.” Cocaine use has not been a significant problem. The primary mode of treatment in Poland is long-term residential treatment. In addition, there are ongoing efforts to decrease HIV risk through the provision of clean needles. The government and substance abuse treatment system in Poland is currently considering methadone maintenance treatment and faculty of the New Haven/Gdańsk Exchange Program have been able to contribute to that discussion.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.